Oxford Biomedica ShareCast News (OXB)

Oxford Biomedica bags Novartis leukaemia deal

Pharmaceutical giant Novartis has signed up biotech firm Oxford Biomedica to provide its gene delivery technology for a programme targeting various forms of leukaemia.
[1 May '13]

Revenue rises to 7.8m pounds in full year at Oxford Biomedica

Gene-based biopharmaceutical company Oxford BioMedica has reported that revenue rose to 7.8m pounds in the full year 2012 from 7.7m pounds one year earlier.
[27 Feb '13]

Oxford BioMedica halts trial due to poor recruitment

Oxford BioMedica, a gene-based biopharmaceutical company, has made a strategic decision to close the US trial of its TroVax product on patients with progressive hormone refractory prostate cancer (HRPC) because recruitment has been much slower than originally anticipated.
[10 Oct '12]

Small caps round-up: Brady, Oxford BioMedica, Densitron Tech

Brady, a provider of trading, risk management and settlement solutions to the energy, metals and commodities sectors, has said that it is in a payment dispute over software with a customer that it signed in 2011.
[31 Aug '12]

Small Caps round-up: eXpansys, Oxford Biomedica, Dawson International

eXpansys, the online electronics retailer has delivered a 33 per cent increase in turnover in the 12 months to the end of April. Total revenues for the year were 108.5m pounds, up 24pc on a like-for-like basis. Profits before tax were 4.3m pounds, a rise of 27pc on the prior year. The market had clearly been expecting better, the stock was down 3.8pc at 10:34.
[8 Aug '12]

Small caps round-up: Quadrise, Software Radio, Motive Television ...

Also covered: Oxford Biomedica
[8 Jun '12]

Small caps round-up: Sportech, Silverdell, Oxford BioMedica

Also covered by the round-up: RM, SnackTime, Braveheart Investment Group and Planet Payment.
[11 May '12]

Small caps round-up: Omega Diagnostics, Oxford Biomedica, i-design ...

Also included in this round-up: Brainspark
[16 Apr '12]